Science Explorer Interactive view Map

Inovio Pharmaceuticals (United States)

World rank, all time
#12,970
of 42,892
Rank in United States
#2,835
of 8,685
Research works
150
▼ 38% vs 2013–17
Citations
5.5k
36.4 per fractional work
Top-10% rate
33.0%
record average 16.5%
Open access
54%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.87× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.76× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 14.22× its world share, 2 worksImmunology and Micro…Engineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.58× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.51× its world share, 0 worksHealth ProfessionsMedicine: 3.01× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 0.10× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.19× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.2×. Every wedge is a field page.

Who are the top researchers at Inovio Pharmaceuticals (United States)?

Ranked on the composite score, Kate E. Broderick, Niranjan Y. Sardesai and Laurent Humeau lead among researchers whose main affiliation is Inovio Pharmaceuticals (United States).

  1. 1 Kate E. Broderick United States · #314,216 worldwide 71 citations · 23 works
  2. 2 Niranjan Y. Sardesai United States · #432,304 worldwide 65 citations · 30 works
  3. 3 Laurent Humeau United States · #593,398 worldwide 59 citations · 19 works
  4. 4 Matthew P. Morrow United States · #764,344 worldwide 24 citations · 22 works
All ranked researchers at Inovio Pharmaceuticals (United States)

Which keywords describe research at Inovio Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunity, Immune Response, Gene Therapy, Vaccine, Epidemiology, Antigen Presentation, Cancer Immunotherapy and Innate Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology24▲ 3.9×36 topics
  2. Immunity18▲ 35×5 topics
  3. Immune Response18▲ 19×15 topics
  4. Gene Therapy18▲ 44×4 topics
  5. Vaccine17▲ 28×11 topics
  6. Antigen Presentation17▲ 112×2 topics
  7. Cancer Immunotherapy15▲ 73×2 topics
  8. Innate Immunity15▲ 29×4 topics
  9. Dendritic Cells14▲ 79×2 topics
  10. Tumor Antigen14▲ 110×1 topic
  11. Vaccine Adjuvants14▲ 110×1 topic
  12. Biopharmaceuticals10▲ 102×3 topics
  13. Recombinant Proteins10▲ 129×2 topics
  14. Plant Molecular Farming10▲ 264×1 topic
  15. Vaccine Antigens10▲ 264×1 topic
  16. Pathogenesis10▲ 11×13 topics
  17. Electroporation9▲ 274×1 topic
  18. Irreversible Electroporation9▲ 274×1 topic
  19. Global Burden8▲ 10×3 topics
  20. Cancer Therapy7▲ 7.7×7 topics
  21. Pandemic6▲ 9.1×4 topics
  22. Vaccine Development6▲ 13×7 topics
  23. Coronavirus6▲ 33×3 topics
  24. Antibodies6▲ 42×2 topics
  25. Human Papillomavirus6▲ 29×3 topics
  26. Antiretroviral Therapy5▲ 15×3 topics
  27. Antiviral Therapy5▲ 23×3 topics
  28. SARS-CoV-25▲ 24×5 topics
  29. Targeted Therapy5▲ 16×5 topics
  30. Gene Silencing5▲ 27×2 topics
  31. Immunotoxin5▲ 101×1 topic
  32. Ricin Poisoning5▲ 101×1 topic
  33. Liver Disease5▲ 23×2 topics
  34. ACE2 Receptor5▲ 26×2 topics
  35. Cervical Cancer5▲ 31×2 topics
  36. Viral Transmission5▲ 32×2 topics
  37. AIDS4▲ 56×1 topic
  38. Cancer Incidence4▲ 21×1 topic
  39. HIV4▲ 25×1 topic
  40. HPV Vaccination4▲ 58×1 topic

Which research topics does Inovio Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Medical Imaging and Pathology Studies and Monoclonal and Polyclonal Antibodies Research.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  2. 2 Immunotherapy and Immune Responses Immunology 1 works
  3. 3 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Animal Virus Infections Studies Animal Science and Zoology 0 works
  6. 6 Cervical Cancer and HPV Research Epidemiology 0 works
  7. 7 Hepatitis B Virus Studies Epidemiology 0 works
  8. 8 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  9. 9 Microbial Inactivation Methods Biotechnology 0 works
  10. 10 vaccines and immunoinformatics approaches Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.9%not open46.1%

World: 28% of research is openly available.

with international co-authors17.3%domestic only82.7%

World: 19% is written across borders.

How has Inovio Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 38% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Plymouth Meeting

All research institutions in Plymouth Meeting

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.